Legal & General Group’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-5,175
| Closed | -$47.2K | – | 3448 |
|
|
2025
Q2 | $47.2K | Sell |
5,175
-4,571
| -47% | -$33.6K | ﹤0.01% | 2720 |
|
|
2025
Q1 | $77.5K | Sell |
9,746
-56,178
| -85% | -$411K | ﹤0.01% | 2688 |
|
|
2024
Q4 | $358K | Buy |
65,924
+4,267
| +7% | +$26.1K | ﹤0.01% | 2570 |
|
|
2024
Q3 | $445K | Buy |
61,657
+2,556
| +4% | +$23.4K | ﹤0.01% | 2503 |
|
|
2024
Q2 | $642K | Sell |
59,101
-688
| -1% | -$8.81K | ﹤0.01% | 2334 |
|
|
2024
Q1 | $1.12M | Buy |
59,789
+1,475
| +3% | +$34K | ﹤0.01% | 2156 |
|
|
2023
Q4 | $1.26M | Buy |
58,314
+835
| +1% | +$16.5K | ﹤0.01% | 2127 |
|
|
2023
Q3 | $1.18M | Sell |
57,479
-402
| -0.7% | -$11.6K | ﹤0.01% | 2128 |
|
|
2023
Q2 | $2.72M | Buy |
57,881
+7,601
| +15% | +$378K | ﹤0.01% | 1775 |
|
|
2023
Q1 | $2.11M | Buy |
50,280
+5,182
| +11% | +$223K | ﹤0.01% | 1860 |
|
|
2022
Q4 | $1.72M | Sell |
45,098
-153
| -0.3% | -$5.84K | ﹤0.01% | 1954 |
|
|
2022
Q3 | $1.77M | Sell |
45,251
-3,813
| -8% | -$147K | ﹤0.01% | 1924 |
|
|
2022
Q2 | $1.58M | Sell |
49,064
-43,243
| -47% | -$1.45M | ﹤0.01% | 1995 |
|
|
2022
Q1 | $3.06M | Buy |
92,307
+6,436
| +7% | +$242K | ﹤0.01% | 1790 |
|
|
2021
Q4 | $3.65M | Sell |
85,871
-7,832
| -8% | -$328K | ﹤0.01% | 1735 |
|
|
2021
Q3 | $4.15M | Buy |
93,703
+10,058
| +12% | +$461K | ﹤0.01% | 1651 |
|
|
2021
Q2 | $4.75M | Buy |
83,645
+51,610
| +161% | +$3.65M | ﹤0.01% | 1557 |
|
|
2021
Q1 | $2.4M | Buy |
32,035
+423
| +1% | +$34.7K | ﹤0.01% | 1899 |
|
|
2020
Q4 | $2.73M | Sell |
31,612
-10,730
| -25% | -$791K | ﹤0.01% | 1758 |
|
|
2020
Q3 | $2.59M | Buy |
42,342
+557
| +1% | +$28.2K | ﹤0.01% | 1660 |
|
|
2020
Q2 | $1.74M | Buy |
41,785
+2,487
| +6% | +$90.3K | ﹤0.01% | 1783 |
|
|
2020
Q1 | $1.13M | Sell |
39,298
-283
| -0.7% | -$16.4K | ﹤0.01% | 1815 |
|
|
2019
Q4 | $2.86M | Buy |
39,581
+4,943
| +14% | +$608K | ﹤0.01% | 1621 |
|
|
2019
Q3 | $4.86M | Buy |
34,638
+4,594
| +15% | +$768K | ﹤0.01% | 1313 |
|
|
2019
Q2 | $5.5M | Buy |
30,044
+4,601
| +18% | +$785K | ﹤0.01% | 1240 |
|
|
2019
Q1 | $4.05M | Buy |
25,443
+2,404
| +10% | +$348K | ﹤0.01% | 1332 |
|
|
2018
Q4 | $2.21M | Buy |
23,039
+1,902
| +9% | +$218K | ﹤0.01% | 1536 |
|
|
2018
Q3 | $2.98M | Buy |
21,137
+21
| +0.1% | +$3.24K | ﹤0.01% | 1503 |
|
|
2018
Q2 | $3.31M | Buy |
21,116
+3,535
| +20% | +$555K | ﹤0.01% | 1380 |
|
|
2018
Q1 | $2.83M | Buy |
17,581
+629
| +4% | +$107K | ﹤0.01% | 1427 |
|
|
2017
Q4 | $2.8M | Buy |
16,952
+2,132
| +14% | +$207K | ﹤0.01% | 1434 |
|
|
2017
Q3 | $924K | Buy |
14,820
+2,588
| +21% | +$203K | ﹤0.01% | 1897 |
|
|
2017
Q2 | $969K | Buy |
12,232
+1,484
| +14% | +$107K | ﹤0.01% | 1841 |
|
|
2017
Q1 | $755K | Buy |
10,748
+934
| +10% | +$54.7K | ﹤0.01% | 1903 |
|
|
2016
Q4 | $497K | Buy |
9,814
+4,099
| +72% | +$193K | ﹤0.01% | 1981 |
|
|
2016
Q3 | $262K | Buy |
5,715
+301
| +6% | +$12.3K | ﹤0.01% | 1962 |
|
|
2016
Q2 | $157K | Buy |
5,414
+1,268
| +31% | +$42.3K | ﹤0.01% | 1868 |
|
|
2016
Q1 | $134K | Buy |
4,146
+607
| +17% | +$21.4K | ﹤0.01% | 1888 |
|
|
2015
Q4 | $205K | Buy |
3,539
+1,218
| +52% | +$60.3K | ﹤0.01% | 1735 |
|
|
2015
Q3 | $96K | Hold |
2,321
| – | – | ﹤0.01% | 2066 |
|
|
2015
Q2 | $163K | Buy |
+2,321
| New | +$149K | ﹤0.01% | 1834 |
|
Other funds holding SAGE
IA
HNB